Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 32
Filtrar
Mais filtros

Bases de dados
País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
1.
Adv Dent Res ; 23(2): 237-46, 2011 May.
Artigo em Inglês | MEDLINE | ID: mdl-21490236

RESUMO

The mouth and oropharynx are among the ten most common sites affected by cancer worldwide, but global incidence varies widely. Five-year survival rates exceed 50% in only the best treatment centers. Causes are predominantly lifestyle-related: Tobacco, areca nut, alcohol, poor diet, viral infections, and pollution are all important etiological factors. Oral cancer is a disease of the poor and dispossessed, and reducing social inequalities requires national policies co-ordinated with wider health and social initiatives - the common risk factor approach: control of the environment; safe water; adequate food; public and professional education about early signs and symptoms; early diagnosis and intervention; evidence-based treatments appropriate to available resources; and thoughtful rehabilitation and palliative care. Reductions in inequalities, both within and between countries, are more likely to accrue from the application of existing knowledge in a whole-of-society approach. Basic research aimed at determining individual predisposition and acquired genetic determinants of carcinogenesis and tumor progression, thus allowing for targeted therapies, should be pursued opportunistically.


Assuntos
Pesquisa em Odontologia , Saúde Global , Disparidades nos Níveis de Saúde , Neoplasias Bucais/epidemiologia , Saúde Bucal , Consumo de Bebidas Alcoólicas/efeitos adversos , Areca/efeitos adversos , Educação em Saúde , Política de Saúde , Prioridades em Saúde , Acessibilidade aos Serviços de Saúde , Humanos , Incidência , Programas de Rastreamento , Neoplasias Bucais/etiologia , Neoplasias Bucais/terapia , Lesões Pré-Cancerosas , Fatores de Risco , Fatores Socioeconômicos , Nicotiana/efeitos adversos , Resultado do Tratamento
2.
Clin Cancer Res ; 5(7): 1862-7, 1999 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-10430093

RESUMO

Patients with squamous cell carcinoma of the head and neck (HNSCC) often develop second carcinomas elsewhere in the upper aerodigestive tract. Some of these paired tumors share a common origin, reflecting the ability of a single progenitor cell to replicate, expand, and populate contiguous regions of the upper aerodigestive tract-a process referred to as clonal expansion. The geographical limitations of clonal expansion, however, have not been adequately addressed. For example, it is not known whether a neoplastic clone from the oral cavity, pharynx, or larynx can migrate to the esophagus. We compared paired tumors from 16 patients with HNSCC and a second squamous cell carcinoma of the esophagus (ESCC) for patterns of allelic loss on chromosomal arms 3p, 9p, and 17p. Losses at these loci occur early during neoplastic transformation of the respiratory tract. In 14 cases (87%), the paired tumors had discordant patterns of allelic loss, suggesting that these tumors were not clonally related. Conversely, two (13%) of the 16 paired tumors had identical genetic alterations, which suggests clonal expansion as the mechanism underlying tumor multifocality. One clone spread from the hypopharynx into the cervical esophagus, and the other spread from the tonsil to the distal esophagus. Although most second ESCCs appear to arise as independent neoplasms, a clonal population of neoplastic cells is capable of traveling across substantial distances to give rise to second tumors at different anatomical sites.


Assuntos
Carcinoma de Células Escamosas/genética , Neoplasias Esofágicas/genética , Neoplasias de Cabeça e Pescoço/genética , Repetições de Microssatélites/genética , Segunda Neoplasia Primária/genética , Cromossomos Humanos Par 17 , Cromossomos Humanos Par 3 , Cromossomos Humanos Par 9 , Células Clonais , DNA de Neoplasias/análise , Humanos , Perda de Heterozigosidade
3.
J Periodontol ; 66(5): 321-8, 1995 May.
Artigo em Inglês | MEDLINE | ID: mdl-7623250

RESUMO

The purpose of this study was to determine the clinical course of early onset periodontitis and to investigate factors which may influence its clinical course. For the past 15 years we have been conducting a study of families with early onset periodontitis, and have examined 142 localized juvenile periodontitis and 185 severe generalized early onset periodontitis patients. In order to study the clinical course of early onset periodontitis we recalled our subject population to determine their periodontal status. Forty (40) patients with localized early onset periodontitis (LJP) and 48 with generalized early onset periodontitis (SP) were re-examined. The time since the most recent visit for LJP patients was approximately 3 years and for SP patients almost 4 years. LJP patients who received periodontal therapy on the average gained periodontal attachment. In contrast, LJP patients who did not receive therapy lost periodontal attachment. SP patients lost periodontal attachment regardless of whether or not they had periodontal therapy. SP patients also lost an average of one tooth during the approximately 4 years of observation. LJP patients lost very few teeth with only 4 teeth being lost in 40 patients. The results of this study suggest that localized juvenile periodontitis is a stable disease in most individuals. In contrast, patients with severe generalized early onset periodontitis continued to lose both periodontal attachment and teeth.


Assuntos
Periodontite/patologia , Adulto , Periodontite Agressiva/patologia , Periodontite Agressiva/terapia , Análise de Variância , Doença Crônica , Raspagem Dentária , Progressão da Doença , Feminino , Humanos , Estudos Longitudinais , Masculino , Perda da Inserção Periodontal/complicações , Perda da Inserção Periodontal/patologia , Periodontite/terapia , Perda de Dente/etiologia
4.
Am J Public Health ; 85(1): 48-54, 1995 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-7832261

RESUMO

OBJECTIVES: The purpose of this study was to develop a model, using the epidemiologic tool of attributable risk, for estimating the cost of substance abuse to Medicaid. METHODS: Based on prior substance-use and morbidity research, population attributable risks for substance abuse-related diseases were calculated. (These risks measure the proportion of total disease cases attributable to smoking, drinking, and drug use.) The risks for each disease were applied to Medicaid hospital discharges and days on the 1991 National Hospital Discharge Survey that had these diseases as primary diagnoses. The cost of these substance abuse-related days were added to Medicaid hospital costs for direct treatment of substance abuse. RESULTS: More than 60 medical conditions involving 1100 diagnoses were identified, at least in part, as attributable to substance abuse. Factoring these substance abuse-related conditions into hospital costs, 1 out of 5 Medicaid hospital days, or 4 million days, were spent on substance abuse-related care in 1991. In 1994, this would account for almost $8 billion in Medicaid expenditures. CONCLUSIONS: The use of tobacco, alcohol, and drugs contributes significantly to hospital costs. To address rising costs, substance abuse treatment and prevention should be an integral part of any health care reform effort.


Assuntos
Custos Hospitalares , Medicaid/economia , Fumar/economia , Transtornos Relacionados ao Uso de Substâncias/economia , Alcoolismo/complicações , Alcoolismo/economia , Feminino , Humanos , Drogas Ilícitas , Masculino , Gravidez , Complicações na Gravidez/economia , Fumar/efeitos adversos , Transtornos Relacionados ao Uso de Substâncias/complicações , Estados Unidos
6.
Hosp Health Netw ; 67(17): 56, 1993 Sep 05.
Artigo em Inglês | MEDLINE | ID: mdl-8353567

RESUMO

Joseph A. Califano Jr. was secretary of Health, Education and Welfare in the Carter administration and is now president of the Center on Addiction and Substance Abuse at Columbia University, an independent not-for-profit research center. He also serves as an adjunct professor of public health at Columbia University. Califano has written eight books, including America's Health Care Revolution: Who Lives? Who Dies? Who Pays?, published in 1986. He will speak at the American Society for Healthcare Marketing and Public Relations 15th annual meeting, Sept. 11-14 in San Francisco. He spoke recently with Senior Editor Terese Hudson about the possibilities and problems in the current move to reform health care.


Assuntos
Planos de Assistência de Saúde para Empregados/legislação & jurisprudência , Política de Saúde/legislação & jurisprudência , Controle de Custos/legislação & jurisprudência , Humanos , Qualidade da Assistência à Saúde/economia , Transtornos Relacionados ao Uso de Substâncias/economia , Transtornos Relacionados ao Uso de Substâncias/terapia , Estados Unidos
8.
Arch Inst Cardiol Mex ; 59(3): 241-4, 1989.
Artigo em Espanhol | MEDLINE | ID: mdl-2506843

RESUMO

We studied the effects of intravenous flecainide acetate, given as a single dose of 2 mg/kg in no less than 15 minutes, on 31 patients with supraventricular tachyarrhythmias. Fourteen (87%) of the 16 patients with paroxysmal atrial fibrillation converted to sinus node rhythm. All 7 (100%) of the patients with paroxysmal supraventricular tachycardia converted to sinus node rhythm. Five (60%) of the 8 patients with paroxysmal atrial flutter converted to sinus node rhythm. The average time of conversion, after completion of drug administration, was 15 +/- 20 minutes. The QRS was prolonged an average of 82 to 91 milliseconds; in those cases who converted, the PR interval duration was 180 milliseconds average; QT was prolonged an average of 425-450 milliseconds. There were no changes in the JT interval, and we observed no hemodynamic untoward effects.


Assuntos
Fibrilação Atrial/tratamento farmacológico , Flutter Atrial/tratamento farmacológico , Flecainida/uso terapêutico , Taquicardia Supraventricular/tratamento farmacológico , Adulto , Idoso , Avaliação de Medicamentos , Feminino , Flecainida/administração & dosagem , Humanos , Injeções Intravenosas , Masculino , Pessoa de Meia-Idade
9.
Consultant ; 29(1): 58-60, 63, 66, 1989 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-10291549

RESUMO

Using his experience with Chrysler Motors as an example, the author tells how waste, inefficiency, and greed shaped a corporate health care system that, if it continued, could have blocked the corporation's recovery. An intense investigation of the use and abuse of this plan resulted in savings of about $100 million over an initial two-year period, with an additional $250 million savings projected over the following five years. In considering future changes in the country's health care system, he comments on the need for hospital cutbacks; reduction in unwarranted variations in medical practice; dissemination of necessary information to both individual and corporate purchasers of health care; increasing utilization of nurses in the medical arts; changes in the medical malpractice system; an increase in corporation case management systems; and competition among providers, which, by reducing costs, will most likely result in an efficient health care system for all people.


Assuntos
Atenção à Saúde/tendências , Planos de Assistência de Saúde para Empregados/economia , Indústrias , Seguro Saúde/economia , Controle de Custos/métodos , Governo , Michigan
12.
Health Matrix ; 3(3): 32-6, 1985.
Artigo em Inglês | MEDLINE | ID: mdl-10280936

RESUMO

Americans have been playing "The Great Health Care Shell Game" with health care costs far too long. Action must be taken by all the players--employers, unions, government, doctors, and patients--to eliminate the inefficiencies and reduce the cost of health care for our society. The cost-plus and fee-for-service reimbursement systems must be eliminated and all patients must become more cognizant of the cost of their own health care. The alternative is to permit Uncle Sam to play King Solomon with lives--to decide who should benefit from scientific advances and who should not.


Assuntos
Controle de Custos , Economia Médica/tendências , Mau Uso de Serviços de Saúde/economia , Serviços de Saúde/economia , Indústrias , Hospitais , Estados Unidos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA